机构:[1]Department of Ophthalmology, Beijing Children’s Hospital, Capital Medical University, Beijing, China临床科室眼科首都医科大学附属北京儿童医院[2]Department of Ophthalmology, Beijing Tongren Hospital, Capital Medical University, Beijing, China首都医科大学附属同仁医院[3]Department of Ophthalmology, Quanzhou Children’s Hospital, Quanzhou, China[4]Hematology and Oncology Centre, Beijing Children’s Hospital, Capital Medical University, Beijing, China医技科室血液中心首都医科大学附属北京儿童医院[5]Department of Paediatrics, Beijing Tongren Hospital, Capital Medical University, Beijing, China首都医科大学附属同仁医院[6]Departments of Ophthalmology & Vision Science, Hospital for Sick Children and University of Toronto, Toronto, Canada[7]Techna Institute, University Health Network, Toronto, Canada
第一作者机构:[1]Department of Ophthalmology, Beijing Children’s Hospital, Capital Medical University, Beijing, China
通讯作者:
通讯机构:[6]Departments of Ophthalmology & Vision Science, Hospital for Sick Children and University of Toronto, Toronto, Canada[7]Techna Institute, University Health Network, Toronto, Canada[*1]Departments of Ophthalmology & Vision Science, Hospital for Sick Children and University of Toronto, Toronto, ON M5G1X8 Canada
推荐引用方式(GB/T 7714):
Zhao Junyang,Li Qiyan,Wu Songyi,et al.Re: Zhao et al.: Pars plana vitrectomy and endoresection of refractory intraocular retinoblastoma (Ophthalmology. 2018; 125: 320-322) REPLY[J].OPHTHALMOLOGY.2018,125(7):E50-E51.doi:10.1016/j.ophtha.2018.02.033.
APA:
Zhao, Junyang,Li, Qiyan,Wu, Songyi,Jin, Liwen,Ma, Xiaolin...&Gallie, Brenda.(2018).Re: Zhao et al.: Pars plana vitrectomy and endoresection of refractory intraocular retinoblastoma (Ophthalmology. 2018; 125: 320-322) REPLY.OPHTHALMOLOGY,125,(7)
MLA:
Zhao, Junyang,et al."Re: Zhao et al.: Pars plana vitrectomy and endoresection of refractory intraocular retinoblastoma (Ophthalmology. 2018; 125: 320-322) REPLY".OPHTHALMOLOGY 125..7(2018):E50-E51